Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Off-label dermatologic therapies. Usage, risks, and mechanisms

V W Li1, M P Jaffe, W W Li

  • 1Department of Medicine, Brigham and Women's Hospital, Boston, Mass., USA.

Archives of Dermatology
|November 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Brain functional and cognitive features in schizophrenia patients with positive and negative symptom features based on resting-state functional MRI].

Zhonghua yi xue za zhi·2026
Same author

[Treatment practice and outcomes in 125 patients with autoimmune hemolytic anemia: a single-center retrospective analysis].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2026
Same author

[Prefrontal near-infrared spectroscopy characteristics in patients with schizophrenia during verbal fluency tasks and their association with clinical efficacy].

Zhonghua yi xue za zhi·2026
Same author

[A randomized controlled trial of knotless barbed sutures for wound closure in short-segment posterior lumbar decompression and fusion surgery].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2026
Same author

[Incidence and associated factors of tyrosine kinase inhibitor withdrawal syndrome and psychological issues in patients with chronic-phase chronic myeloid leukemia after therapy discontinuation].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi·2025
Same author

[Clinical prognostic prediction research: a technical roadmap].

Zhonghua yi xue za zhi·2025
Same journal

Scoring With SCORTEN-Reply.

Archives of dermatology·2017
Same journal

Comparison of Early and Late Latent Syphilis- Colorado, 1991.

Archives of dermatology·2016
Same journal

Case of Rhinoscleroma.

Archives of dermatology·2016
Same journal

Cutaneous Fungal Infections.

Archives of dermatology·2016
Same journal

An Ulcerated Plaque in a Gay Man.

Archives of dermatology·2016
Same journal

Solitary Violaceous Nodule on the Face.

Archives of dermatology·2016
See all related articles

Dermatologists commonly prescribe off-label drugs for skin conditions, often with misconceptions about approved uses and legal aspects. Understanding off-label prescribing principles can aid innovative patient therapies.

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Off-label prescribing involves using Food and Drug Administration (FDA)-approved drugs for unapproved indications.
  • Such practices can offer therapeutic benefits for various dermatologic conditions, including those related to angiogenesis.

Purpose of the Study:

  • To assess dermatologists' use of off-label drugs for specific skin conditions.
  • To evaluate their perceptions regarding FDA-approved versus off-label indications.
  • To understand their attitudes towards off-label therapies.

Main Methods:

  • A survey was conducted among 55 dermatologists at a single large academic institution.
  • The survey assessed drug prescribing patterns, perceptions of indication approval, and attitudes toward off-label use.

Related Experiment Videos

Main Results:

  • Off-label drug prescribing is prevalent among surveyed dermatologists.
  • Many respondents demonstrated misperceptions regarding FDA-approved indications and the legal implications of off-label prescribing.

Conclusions:

  • Clinicians' understanding of off-label prescribing principles and drug mechanisms is crucial.
  • This knowledge can empower dermatologists to judiciously employ innovative therapies for patient benefit.